Pharma Journalist 9027 posts 0 comments

AbbVie announced the European Commission (EC) approved RINVOQ (upadacitinib), an oral, selective and reversible JAK inhibitor, for the treatment of moderate to severe atopic dermatitis…
Read More...

Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical need and large public health burden, announced that its…
Read More...

InDex Pharmaceuticals Holding AB (publ) announced that the U.S. Food and Drug Administration (FDA) has given clearance to start the phase III clinical study CONCLUDE in the United…
Read More...

Pfizer Inc. and Trillium Therapeutics Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical stage…
Read More...

Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for COMIRNATY (COVID-19 Vaccine, mRNA) to prevent…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Orencia (abatacept) for the…
Read More...

BioDuro-Sundia, a leading drug discovery and development services organization backed by Advent International, announced today it has entered into a definitive agreement to acquire a…
Read More...

Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, announced that…
Read More...

JW Therapeutics an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy, announced that it has entered into a strategic…
Read More...

We are pleased to announce the Advanced RWE Applications in Pharma Summit (formerly IMPACCT) is returning on October 26-28, 2021, for its 9th year. This year we will unite the RWE…
Read More...